We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · March 08, 2021

Effect of High-Dose Zinc and Ascorbic Acid on Symptoms in Ambulatory Patients With SARS-CoV-2

JAMA Network Open


Additional Info

JAMA Network Open
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial
JAMA Netw Open 2021 Feb 01;4(2)e210369, S Thomas, D Patel, B Bittel, K Wolski, Q Wang, A Kumar, ZJ Il'Giovine, R Mehra, C McWilliams, SE Nissen, MY Desai

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading